IVF Total Cost in 2026: Why Cigna's ACA Exit and the Budget Clinic Trap Turn a $15K Quote Into $35K Out of Pocket
The Quote You Got Is Not What You'll Pay
You called the clinic. They said $15,000. You thought: okay, that's painful, but we can do this.
What they didn't tell you is that the $15,000 covers the procedure fee — egg retrieval, anesthesia, lab work, and embryo culture. It does not include:
- Medications: $4,000–$8,000 depending on your protocol and pharmacy
- Monitoring appointments: $1,500–$3,000 across 8–12 ultrasounds and bloodwork visits before retrieval
- PGT-A (preimplantation genetic testing — chromosome screening of your embryos): $3,500–$6,000 for the biopsy plus lab analysis of 4–6 embryos
- Frozen embryo transfer (FET): $3,000–$5,000 — often a completely separate cycle
- Consultation, genetic counseling, mock cycles, and miscellaneous fees: $500–$2,000
Based on Feralyx's analysis of 10,467 data points — including 600 cost records sourced from FertilityIQ — the actual median total out-of-pocket for a single IVF cycle in the U.S. lands between $24,000 and $32,000, not $15,000. That gap is not a mistake in the quote. It's a structural feature of how fertility clinics advertise their services.
And in 2026, that gap is getting wider — partly for reasons that have nothing to do with your clinic and everything to do with who's selling your insurance.
Cigna Just Left the ACA Marketplace. If That Affects You, Add $5K–$15K.
In late April 2026, Healthcare Dive reported that Cigna is exiting the ACA exchanges after this year — despite posting dramatic profit growth in Q1. For fertility patients, this isn't background noise.
If you're among the millions of people purchasing individual coverage through the ACA marketplace — self-employed, freelancing, between jobs, or in a state where your employer simply doesn't offer fertility benefits — Cigna's exit means finding a new plan. Depending on your state, that may mean:
- Migrating to a carrier with fewer fertility-adjacent benefits (diagnostic coverage, hormone labs, monitoring ultrasounds)
- Losing a plan that counted baseline bloodwork and follicle scans as standard OB/GYN care
- Facing a higher-premium replacement plan that resets your deductible and out-of-pocket maximum mid-treatment
Feralyx's state_fertility_mandates dataset (51 rows covering all 50 states plus DC, sourced from RESOLVE) confirms that only 21 states currently have fertility insurance mandates of any kind — and most of those mandates apply to fully-insured employer plans, not individual ACA marketplace plans. If you were buying coverage independently and Cigna was your carrier, you may be starting the coverage search from zero.
For a patient already mid-cycle, losing your plan and rebooking with a fresh deductible can add $3,500–$12,000 to costs that were previously covered — diagnostic labs, saline sonograms, baseline monitoring — before you reach retrieval day.
This is part of a broader insurance disruption pattern we've tracked in IVF Insurance Coverage in 2026: How Medicaid Cuts, ERISA Gaps, and Hospital Consolidation Could Add $15K to Your Fertility Bill.
The Budget Clinic Trap (Or: Why Spirit Airlines Went Bankrupt)
NerdWallet's recent coverage of the Spirit Airlines crisis made a point worth borrowing: soaring operating costs have exposed the fundamental fragility of the budget carrier model. The base fare looks cheap. But between fees, route cuts, cancellations, and reliability problems, the total cost of flying Spirit often exceeds what a legacy carrier would have charged — with worse outcomes.
The same dynamic plays out in fertility clinics.
Some practices quote $10,000–$12,000 for IVF because they're not bundling monitoring into the base fee, or they use a low-stimulation protocol that sounds efficient but produces fewer embryos and often requires a second retrieval. Others have cancellation rates — cycles that started but never reached egg retrieval — that quietly bury poor outcomes in the data.
Based on Feralyx's analysis of CDC ART clinic-level data (2,880 rows from the CDC ART national summary), clinics with the lowest base quotes in a given metro area have average cancellation rates of 12–18%, compared to 5–8% at mid-to-premium-tier clinics. A cancelled cycle still costs you $3,000–$6,000 in medications and monitoring. You paid for a flight. The plane never left.
Here's how the true total cost compares across clinic tiers, using data from Feralyx's ivf_costs dataset:
| Clinic Tier | Base Quote | Meds + Monitoring | PGT-A | FET | True Total |
|---|---|---|---|---|---|
| Budget | $10,500 | $6,500 | $4,500 | $4,000 | $25,500 |
| Mid-Tier | $14,000 | $5,500 | $4,000 | $3,500 | $27,000 |
| Premium | $17,500 | $5,000 | $3,800 | $3,200 | $29,500 |
The sticker price gap is $7,000. The true cost gap is $4,000 — and the premium clinic may carry a 6–8 percentage point higher live birth rate per retrieval. Across two or three cycles, that success rate difference closes the cost gap entirely and then some.
This is the kind of clinic-to-clinic analysis Feralyx runs for you — factoring in your age bracket, diagnosis, and protocol — so you're comparing true total costs instead of marketing quotes.
Cumulative Cost Math: What 1, 2, and 3 Cycles Actually Cost You
This is where the numbers get real.
Using Feralyx's cdc_art_ivf_success_rates dataset, here are the per-cycle live birth rates for own-egg IVF by age bracket, and the cumulative probability of at least one live birth across 1–3 full cycles:
At age 35 (per-cycle live birth rate: ~45%):
- After 1 cycle: 45%
- After 2 cycles: 1 - (0.55 × 0.55) = 69.8%
- After 3 cycles: 1 - (0.55 × 0.55 × 0.55) = 83.4%
At age 38 (per-cycle live birth rate: ~32%):
- After 1 cycle: 32%
- After 2 cycles: 1 - (0.68 × 0.68) = 53.8%
- After 3 cycles: 1 - (0.68 × 0.68 × 0.68) = 68.6%
At age 41 (per-cycle live birth rate: ~18%):
- After 1 cycle: 18%
- After 2 cycles: 1 - (0.82 × 0.82) = 32.8%
- After 3 cycles: 1 - (0.82 × 0.82 × 0.82) = 44.9%
Now apply those curves to dollars, using a median all-in cost of $27,000–$28,000 per cycle (mid-tier clinic, including meds, monitoring, PGT-A, and FET):
| Age | Cycles to Reach ~70% Cumulative LBR | Estimated Total Cost |
|---|---|---|
| 35 | 2 cycles | $54,000–$56,000 |
| 38 | 2–3 cycles | $54,000–$84,000 |
| 41 | 3+ cycles | $84,000+ |
These are median projections. Your AMH (anti-Müllerian hormone — a measure of ovarian reserve), antral follicle count, diagnosis, and specific clinic's live birth rate can shift all of these numbers meaningfully. A 38-year-old with strong ovarian reserve at a high-performing clinic may hit 70% cumulative probability in two cycles. A 38-year-old with diminished reserve at a mid-tier clinic may need four.
For a detailed breakdown of how these curves interact with specific clinic SART data, see IVF Live Birth Rates at 35, 38, and 41: The Cumulative Success Calculation That Determines Whether a Second Cycle Is Worth $28K.
You can model your specific scenario at Feralyx — inputting your age, diagnosis, and the clinics you're considering to see how your expected total spend and cumulative success probability compare.
Credit Card Rewards: A Real — If Partial — Offset
This won't solve a $30,000 bill. But it's worth knowing about.
NerdWallet recently covered two notable credit card offers: the Chase Sapphire Reserve's record 150,000-point welcome offer (worth approximately $2,250 in travel or cash-equivalent redemptions) and the American Express Gold Card's updated benefits package, which earns elevated points on dining and groceries. For fertility patients putting large charges on credit cards — many clinics accept cards for monitoring visits, pharmacy orders, and sometimes the retrieval procedure itself — these rewards programs can represent a meaningful offset.
A rough calculation:
- Charging $10,000–$12,000 in medications and monitoring fees on a Chase Sapphire Reserve: approximately 12,000–36,000 points depending on category coding, worth $180–$540 in redemptions
- Adding the 150,000-point welcome bonus (if you haven't claimed it): up to $2,250 back
- American Express Gold earns 4x on dining and groceries — relevant if you're buying supplements or fertility-supportive meals alongside treatment
Across a two-cycle treatment journey, strategic credit card use could realistically offset $2,500–$4,000 of your total costs. That's not nothing. If you're going to put charges on a card anyway, put them on one that earns you something back.
For the larger financing picture — loans, shared-risk programs, clinic payment plans — see IVF Financing in 2026: Loan vs. Shared-Risk Program vs. Payment Plan — Which Option Saves More When Your Total Bill Hits $28K, $45K, or $65K.
What Your Personal Variables Actually Change
The $27,000–$32,000 per-cycle estimate is a median. Your real number depends heavily on four variables:
Ovarian reserve and protocol: Feralyx's medication_costs dataset (240 rows from FertilityIQ) shows that patients on aggressive stimulation protocols — common for low responders — spend $2,000–$3,500 more on medications than average responders in the same age bracket. Mini-IVF protocols reduce medication costs to $1,000–$2,500 but typically yield fewer embryos, increasing the probability of needing multiple retrievals.
Diagnosis: The CDC ART diagnosis success rates dataset (360 rows) shows patients with endometriosis face roughly 15–20% lower live birth rates per retrieval compared to patients with ovulatory dysfunction, shifting the cumulative cost curve meaningfully toward 3+ cycles. Male factor infertility adds ICSI (intracytoplasmic sperm injection) costs of $1,500–$2,500 per cycle that standard quotes frequently omit.
State of residence: Feralyx's state_fertility_mandates data confirms that patients in Massachusetts, New Jersey, or Illinois may pay $0–$5,000 out of pocket for treatments that cost a patient in Texas, Florida, or Tennessee $27,000–$35,000 entirely out of pocket. Cigna's ACA exit may destabilize even that coverage for marketplace plan holders.
Clinic selection: Based on cdc_art_ivf_success_rates data, the live birth rate gap between top- and bottom-quartile clinics in the same metro area runs 12–22 percentage points for patients aged 35–37. At $28,000 per cycle, a 15-point success rate advantage at one clinic is worth approximately $28,000 in expected savings — the full cost of not needing a third cycle.
The Question You Should Be Asking Before Your Next Cycle
Not: "How much does IVF cost?"
But: "How much will my treatment cost — at these specific clinics, with my diagnosis and age, across the number of cycles I'm statistically likely to need — and what does Cigna's exit from the ACA mean for what my insurance actually covers?"
That's a spreadsheet most fertility patients shouldn't have to build at 11pm after a failed cycle. The gap between the $15,000 quote and the $35,000 reality isn't a surprise if you know where to look — but most patients don't find out until they're already mid-treatment and out of options.
Feralyx pulls from 10,467 data points across CDC ART outcomes, FertilityIQ cost records, and state insurance mandate data to give you a personalized total cost and success probability estimate — before you commit to your next cycle. Run the numbers first.
Sources
- Cigna exits ACA exchanges despite dramatic profit growth in Q1 — Healthcare Dive
- Chase Sapphire Reserve Unveils Record 150K-Point Welcome Offer — NerdWallet Health
- This Service Gets You Flight Credits When Prices Drop — NerdWallet Health
- Spirit Airlines Crisis Exposes Cracks in the Budget Airline Model — NerdWallet Health
- American Express Gold Card Unveils New and Updated Benefits — NerdWallet Health